A new dibismuthane bearing a 5,6,7,12-tetrahydrodibenz[c,f][1,5]azabismocine framework was obtained in high yield by a unique reaction of the corresponding organobismuth oxide and organophosphorus compounds with a P(=O)H group.
No takes yet. Share an insight, caveat, or question.
Shimada et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: